An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes-Reference-Cited by-同舟云学术

An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes

Published:2023-02-01 Issue:2 Volume:16 Page:81-94
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Shah Richa¹,Shah Aashaka²,Badawy Sherif M.¹³^ORCID

Affiliation:

1. Division of Hematology, Oncology, and Stem Cell Transplant, Lurie Children’s Hospital of Chicago, Chicago, IL, USA

2. Department of Medical Education, University of Illinois College of Medicine, Chicago, IL, USA

3. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2023.2178409

Reference86 articles.

1. A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia

2. Standards of care guidelines for thalassemia: children’s hospital and research Center Oakland; 2012. [cited 2022 Sep 01]. Available from: https://thalassemia.com/documents/SOCGuidelines2012.pdf

3. Prevalence and Genetic Analysis of α- and β-Thalassemia and Sickle Cell Anemia in Southwest Iran

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Vulnerabilities of Temozolomide-Resistant Glioblastoma Cells: Implications for Targeted Therapies and Overcoming Chemoresistance;2024-03-05

2. Real‐world evidence: Long‐term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years;American Journal of Hematology;2024-03

3. Health‐related quality of life with standard and curative therapies in thalassemia: A narrative literature review;Annals of the New York Academy of Sciences;2024-01-25

4. The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group;Acta Haematologica;2023-12-16

5. Dissecting the potential role of ferroptosis in liver diseases: an updated review;Free Radical Research;2023-04-03